EHealth Net Worth

EHealth Net Worth Breakdown

  EHTH
The net worth of eHealth is the difference between its total assets and liabilities. EHealth's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of EHealth's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. EHealth's net worth can be used as a measure of its financial health and stability which can help investors to decide if EHealth is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in eHealth stock.

EHealth Net Worth Analysis

EHealth's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including EHealth's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of EHealth's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform EHealth's net worth analysis. One common approach is to calculate EHealth's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares EHealth's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing EHealth's net worth. This approach calculates the present value of EHealth's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of EHealth's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate EHealth's net worth. This involves comparing EHealth's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into EHealth's net worth relative to its peers.

Enterprise Value

350.91 Million

To determine if EHealth is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding EHealth's net worth research are outlined below:
eHealth had very high historical volatility over the last 90 days
eHealth currently holds about 164.75 M in cash with (18.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.01.
eHealth has a poor financial position based on the latest SEC disclosures
Roughly 68.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: StockNews.com Upgrades eHealth to Hold - Defense World
EHealth uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in eHealth. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to EHealth's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

EHealth Target Price Consensus

EHealth target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. EHealth's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   5  Buy
Most EHealth analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand EHealth stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of eHealth, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

EHealth Target Price Projection

EHealth's current and average target prices are 7.83 and 8.62, respectively. The current price of EHealth is the price at which eHealth is currently trading. On the other hand, EHealth's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

EHealth Market Quote on 17th of March 2025

Low Price7.76Odds
High Price8.13Odds

7.83

Target Price

Analyst Consensus On EHealth Target Price

Low Estimate7.85Odds
High Estimate9.57Odds

8.625

Historical Lowest Forecast  7.85 Target Price  8.63 Highest Forecast  9.57
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on eHealth and the information provided on this page.

Know EHealth's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as EHealth is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading eHealth backward and forwards among themselves. EHealth's institutional investor refers to the entity that pools money to purchase EHealth's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Cubist Systematic Strategies, Llc2024-12-31
77.6 K
Note, although EHealth's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow EHealth's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 234.45 M.

Market Cap

386.1 Million

Project EHealth's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets 0.01  0.01 
Return On Capital Employed 0.02  0.02 
Return On Assets 0.01  0.01 
Return On Equity 0.02  0.01 
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.36 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.36.
When accessing EHealth's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures EHealth's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of EHealth's profitability and make more informed investment decisions.

Evaluate EHealth's management efficiency

eHealth has return on total asset (ROA) of 0.0182 % which means that it generated a profit of $0.0182 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.011 %, meaning that it created $0.011 on every $100 dollars invested by stockholders. EHealth's management efficiency ratios could be used to measure how well EHealth manages its routine affairs as well as how well it operates its assets and liabilities. As of now, EHealth's Return On Tangible Assets are increasing as compared to previous years. The EHealth's current Return On Capital Employed is estimated to increase to 0.02, while Return On Equity is projected to decrease to 0.01. As of now, EHealth's Intangible Assets are increasing as compared to previous years. The EHealth's current Net Tangible Assets is estimated to increase to about 1.1 B, while Other Assets are projected to decrease to under 147.4 M.
Last ReportedProjected for Next Year
Book Value Per Share 19.96  20.95 
Tangible Book Value Per Share 19.96  20.95 
Enterprise Value Over EBITDA 7.15  7.51 
Price Book Value Ratio 0.47  0.45 
Enterprise Value Multiple 7.15  7.51 
Price Fair Value 0.47  0.45 
Enterprise Value266.5 M350.9 M
Understanding the operational decisions made by EHealth management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue
0.4677
Revenue
532.4 M
Quarterly Revenue Growth
0.273
Revenue Per Share
18.149
Return On Equity
0.011
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EHealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on EHealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EHealth insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

EHealth Corporate Filings

F4
12th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
27th of February 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
8K
26th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
14th of February 2025
Other Reports
ViewVerify
EHealth time-series forecasting models is one of many EHealth's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary EHealth's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

EHealth Earnings Estimation Breakdown

The calculation of EHealth's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of EHealth is estimated to be -0.62 with the future projection ranging from a low of -0.8766 to a high of -0.5841. Please be aware that this consensus of annual earnings estimates for eHealth is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
2.51
-0.88
Lowest
Expected EPS
-0.62
-0.58
Highest

EHealth Earnings Projection Consensus

Suppose the current estimates of EHealth's value are higher than the current market price of the EHealth stock. In this case, investors may conclude that EHealth is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and EHealth's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
581.11%
2.51
-0.62
-1.19

EHealth Earnings per Share Projection vs Actual

Actual Earning per Share of EHealth refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering eHealth predict the company's earnings will be in the future. The higher the earnings per share of EHealth, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

EHealth Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as EHealth, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of EHealth should always be considered in relation to other companies to make a more educated investment decision.

EHealth Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact EHealth's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-25
2024-12-312.26582.510.244210 
2024-11-06
2024-09-30-1.28-1.47-0.1914 
2024-08-07
2024-06-30-0.84-1.17-0.3339 
2024-05-07
2024-03-31-0.62-0.77-0.1524 
2024-02-27
2023-12-311.841.44-0.421 
2023-11-09
2023-09-30-1.38-1.45-0.07
2023-08-08
2023-06-30-1.11-0.960.1513 
2023-05-09
2023-03-31-0.95-0.830.1212 
2023-02-28
2022-12-310.561.140.58103 
2022-11-07
2022-09-30-1.45-1.170.2819 
2022-08-08
2022-06-30-1.15-1.150.0
2022-05-03
2022-03-31-1.19-0.910.2823 
2022-03-01
2021-12-310.940.49-0.4547 
2021-11-08
2021-09-30-1.02-1.78-0.7674 
2021-07-29
2021-06-30-0.61-0.450.1626 
2021-04-29
2021-03-310.070.360.29414 
2021-02-18
2020-12-312.842.32-0.5218 
2020-10-22
2020-09-30-0.58-0.360.2237 
2020-07-23
2020-06-30-0.140.070.21150 
2020-04-23
2020-03-310.220.390.1777 
2020-02-20
2019-12-312.434.131.769 
2019-10-24
2019-09-30-0.63-0.430.231 
2019-07-25
2019-06-30-0.360.10.46127 
2019-04-25
2019-03-31-0.10.330.43430 
2019-02-21
2018-12-311.981.61-0.3718 
2018-10-25
2018-09-30-0.36-0.220.1438 
2018-07-26
2018-06-30-0.37-0.4-0.03
2018-04-26
2018-03-31-0.41-0.070.3482 
2018-03-01
2017-12-31-1.1-0.930.1715 
2017-10-26
2017-09-30-0.71-0.98-0.2738 
2017-07-27
2017-06-30-0.69-0.78-0.0913 
2017-04-27
2017-03-310.391.931.54394 
2017-02-24
2016-12-31-0.84-0.790.05
2016-10-27
2016-09-30-0.05-0.23-0.18360 
2016-07-28
2016-06-300.090.090.0
2016-04-28
2016-03-310.41.10.7175 
2016-02-23
2015-12-31-0.42-0.56-0.1433 
2015-10-29
2015-09-300.160.30.1487 
2015-07-29
2015-06-300.050.320.27540 
2015-04-24
2015-03-31-0.170.130.3176 
2015-02-25
2014-12-31-0.57-0.430.1424 
2014-10-30
2014-09-300.060.080.0233 
2014-07-30
2014-06-300.090.150.0666 
2014-05-01
2014-03-31-0.02-0.08-0.06300 
2014-02-20
2013-12-31-0.05-0.11-0.06120 
2013-10-24
2013-09-300.020.01-0.0150 
2013-07-25
2013-06-300.080.06-0.0225 
2013-04-25
2013-03-310.10.110.0110 
2013-02-14
2012-12-310.130.11-0.0215 
2012-10-25
2012-09-30-0.010.040.05500 
2012-07-26
2012-06-300.050.110.06120 
2012-02-16
2011-12-310.120.11-0.01
2011-10-25
2011-09-300.03-0.01-0.04133 
2011-07-26
2011-06-300.080.120.0450 
2011-04-26
2011-03-310.070.090.0228 
2011-02-16
2010-12-310.190.240.0526 
2010-10-26
2010-09-300.110.110.0
2010-07-27
2010-06-300.150.13-0.0213 
2010-05-03
2010-03-310.140.13-0.01
2010-02-11
2009-12-310.160.20.0425 
2009-10-27
2009-09-300.140.140.0
2009-07-28
2009-06-300.150.160.01
2009-04-28
2009-03-310.120.120.0
2009-02-12
2008-12-310.120.140.0216 
2008-10-30
2008-09-300.120.120.0
2008-07-31
2008-06-300.140.160.0214 
2008-05-01
2008-03-310.120.130.01
2008-02-14
2007-12-310.130.140.01
2007-11-01
2007-09-300.120.140.0216 
2007-07-31
2007-06-300.10.130.0330 
2007-05-03
2007-03-310.090.090.0
2007-02-15
2006-12-310.10.150.0550 

EHealth Corporate Management

Gavin GalimiGeneral VPProfile
Kate CFASenior StrategyProfile
Eli NewbrunMintzSenior ManagerProfile
John DolanChief OfficerProfile
Bill BillingsChief OfficerProfile
Bob ReesSenior OfficerProfile
Jay JenningsSenior FinanceProfile
When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in eHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EHealth. If investors know EHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.976
Earnings Share
(1.19)
Revenue Per Share
18.149
Quarterly Revenue Growth
0.273
Return On Assets
0.0182
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if EHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.